The interaction between Sillence type and BMD in osteogenesis imperfecta.

Area of Science:

• Pediatrics
• Orthopedics
• Genetics

Background:

• Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones.
• Bisphosphonate treatment in children with OI improves bone mineral density (BMD) and reduces fractures.
• Bone strength in OI depends on both BMD and the quality of the organic bone matrix, particularly collagen I.

Purpose of the Study:

• To investigate the interplay between BMD, collagen I quality (Sillence type), and vertebral deformities in children with OI.
• To assess the influence of load (body weight) and bone quality on vertebral deformity prevalence.

Main Methods:

• Cross-sectional, single-center study of 54 children with OI.
• Assessed vertebral deformities, BMD, body weight, and Sillence classification (Type I vs. III/IV).
• Analyzed associations between vertebral deformities and independent factors including BMD, body weight, and the BMD/body weight ratio.

Main Results:

• Vertebral deformities were independently associated with Sillence type (OR: 5.7), BMD (OR: 0.003), and body weight (OR: 1.15).
• A low BMD/body weight ratio was significantly associated with vertebral deformities in OI Type I (OR: 0.04).
• No significant association was found between BMD/body weight ratio and vertebral deformities in OI Types III/IV.

Conclusions:

• BMD and Sillence type are independent predictors of vertebral deformities in children with OI.
• The BMD/body weight ratio is a relevant indicator for vertebral deformities in OI Type I.
• Further research with larger cohorts is needed to clarify the role of the BMD/body weight ratio in OI Types III/IV.